These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 17498123

  • 1. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 2. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Jun; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 3. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 4. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 5. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Dec; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 7. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 8. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 9. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 10. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC.
    J Nephrol; 1999 Mar; 12(2):76-84. PubMed ID: 10378662
    [Abstract] [Full Text] [Related]

  • 11. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum.
    Iwanami N, Iwase H, Takahashi N, Kato K, Itoh A, Takatani T, Makita S, Kobayashi Y, Okamoto M, Nakamura S, Hiki Y, Ishii M.
    J Nephrol; 2008 Mar; 21(1):118-26. PubMed ID: 18264945
    [Abstract] [Full Text] [Related]

  • 12. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A, Monteiro R, Coppo R.
    G Ital Nefrol; 2006 Mar; 23(3):313-22. PubMed ID: 16868911
    [Abstract] [Full Text] [Related]

  • 13. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Mar; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 14. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 15. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC, Poon PY, Lai KN.
    J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
    [Abstract] [Full Text] [Related]

  • 16. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J.
    Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
    [Abstract] [Full Text] [Related]

  • 17. Genetics and immunopathogenesis of IgA nephropathy.
    Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT, Chiang BL.
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):198-213. PubMed ID: 21188648
    [Abstract] [Full Text] [Related]

  • 18. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 19. Primary IgA nephropathy: new insights into pathogenesis.
    Barratt J, Feehally J.
    Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
    [Abstract] [Full Text] [Related]

  • 20. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.